Home
Conditions
Scleroderma, Systemic

Clinical trial condition

Scleroderma, Systemic

Explore clinical trials studying Scleroderma, Systemic. Study availability and eligibility vary by location and protocol.

452 public trials 124 recruiting studies

Refine in advanced search Browse all conditions

Scleroderma, Systemic trial results

Recruiting

CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease

NCT07305116

Conditions: ANCA Associated Systemic Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +25 more
Locations: Children's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis

NCT04356287

Conditions: Connective Tissue Diseases, Mesenchymal Stem Cells, Scleroderma, Systemic, +3 more
Locations: Sir Mortimer B. Davis Jewish General Hospital Montreal, Quebec, Canada

View Trial Details

Recruiting

Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases

NCT06775912

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +16 more
Locations: The First People's Hospital of Lianyungang Lianyungang, Jiangus, China

View Trial Details

Recruiting

Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases

NCT07361094

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +36 more
Locations: Beijing GoBroad Boren Hospital Beijing, China

View Trial Details

Recruiting

Safety and Efficacy of Adipose-Derived Regenerative Cells (ADRCs) for Improving Hand Dysfunction in Systemic Sclerosis

NCT07360808

Conditions: Connective Tissue Diseases, Hand Dysfunction, Scleroderma, Systemic, +3 more
Locations: NanFang Hospital of Southern Medical University Guangzhou, Guangdong, China

Huashan Hospital Fudan University Shanghai, China

View Trial Details

Recruiting

Familial Systemic Scleroderma

NCT07343115

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +4 more
Locations: Service de Médecine interne et Immunologie clinique - CHU de Strasbourg - France Strasbourg, France

View Trial Details

Recruiting

Western Sweden Systemic Sclerosis Project

NCT07345052

Conditions: Connective Tissue Diseases, Fibrosis, Fibrosis Lung, +11 more
Locations: Rheumatology clinics, Sahlgrenska University Hospital Gothenburg, Sweden

View Trial Details

Recruiting

The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life

NCT06675344

Conditions: Cardiovascular Diseases, Connective Tissue Diseases, Embolism and Thrombosis, +14 more
Locations: DelRicht Research Center New Orleans, Louisiana, United States

University of Michigan Ann Arbor, Michigan, United States

University of Pittsburgh and UPMC Scleroderma Center Pittsburgh, Pennsylvania, United States

Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Recruiting

Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma.

NCT04356755

Conditions: Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
Locations: Grenoble Hospital Grenoble, France

Lille Hopsital Lille, France

Marseille Hospital Marseille, France

Montpellier Hospital Montpellier, France

View Trial Details

Recruiting

Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases

NCT06614270

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antiphospholipid Syndrome, +21 more
Locations: the second affiliated hospital Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Scleroderma, Systemic

Scleroderma, Systemic trial results

Related conditions